Fierce Pharma
JANUARY 12, 2024
A preliminary evaluation by the FDA found no evidence that use of popular diabetes and weight-loss drugs from Novo Nordisk and Eli Lilly can cause suicidal thoughts, the U.S. | A preliminary evaluation by the FDA found no evidence that use of popular diabetes and weight-loss drugs from Novo Nordisk and Eli Lilly can cause suicidal thoughts, the U.S. regulator said.
MedCity News
JANUARY 12, 2024
The innovator’s mindset is shifting from solving the problems right in front of us to solving problems once considered impossible to fix. The lines between curable and incurable diseases are blurring in surgery because medical devices are scaling up precision and scaling down the size of anatomy that surgeons can operate on.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JANUARY 12, 2024
When a plaintiff raises allegations of negligence against a company, the claims typically center on defective products that can cause harm. | A group of 24,000 users of Gilead's TDF-based HIV meds argue that the company knowingly shelved a safer HIV med to increase its profits. Now, Gilead will have to prove that a manufacturer can't be held liable for its development timeline of an upgraded product.
MedCity News
JANUARY 12, 2024
Astellas Pharma’s zolbetuximab was on track to become the first gastric cancer drug that targets claudin 18.1, a protein found on cancerous stomach cells. Others with clinical-stage programs addressing this this target include AstraZeneca and Bristol Myers Squibb.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
JANUARY 12, 2024
While the first-mover advantage is often critical in the realm of drug launches, Eli Lilly is often happy to split the pie with its peers. | While the first-mover advantage is often critical in the realm of drug launches, Eli Lilly is often happy to split the pie with its peers. That’s proven true in obesity, where the company recently introduced its dual-action GIP/GLP-1 agonist Zepbound against Novo Nordisk’s Wegovy.
MedCity News
JANUARY 12, 2024
New research found that there are no racial disparities in weight loss results among patients taking obesity drugs. However, the study found that people of color have less access to services like behavioral care or surgical interventions, which are often needed in order for obese patients to lose weight and keep it off.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
JANUARY 12, 2024
Bayer’s AskBio gene therapy unit has started recruiting patients into a phase 2 trial of its AB-1002 candidate for congestive heart failure.
MedCity News
JANUARY 12, 2024
U.S. healthcare is unnecessarily spending millions of dollars on scopes—dollars that could be better spent opening up new service lines, investing in medical equipment, or hiring nurses for improved patient care.
pharmaphorum
JANUARY 12, 2024
The FDA says it can find no evidence of increased risk of suicidal thoughts and self-harm with GLP-1 drugs like Novo Nordisk's Ozempic and Wegovy
PharmaTimes
JANUARY 12, 2024
If successful, the new test could see routine screening introduced in the NHS
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
European Pharmaceutical Review
JANUARY 12, 2024
Using an investment of €120 million, Boehringer Ingelheim is set to expand and upgrade its production site in Koropi, Greece. New technologies at the facility will support the increased manufacturing capacity, the company stated on X. The expansion will boost exports of medicines from Greece to the US market. This will be the case particularly for Jardiance ® , a treatment for type 2 diabetes, chronic heart failure and chronic kidney disease (CKD), according to Boehringer Ingelheim.
pharmaphorum
JANUARY 12, 2024
Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has started a review of the generic and – if approved – Lantheus could be in line for 180 days of market exclusivity as the first company to bring a copycat version of Lutathera (lutetium Lu 177 dotatate) to the US market.
Pharmaceutical Commerce
JANUARY 12, 2024
An overview of a structural approach that guides development of the analytics and related reporting that may assist brands in gaining or maintaining reimbursement positions and maximizing sales.
pharmaphorum
JANUARY 12, 2024
Researchers from the Wellcome Sanger Institute and partners have carried out a comprehensive analysis of cancer cells, identifying 370 ‘priority’ targets that could be used to develop new drug therapies.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Pharmaceutical Technology
JANUARY 12, 2024
Cereno Scientific has announced a partnership with CordenPharma to scale up manufacture of its drug candidate CS1.
European Pharmaceutical Review
JANUARY 12, 2024
According to a paper published in Bioprocess Control , as an advanced process control method, Model Predictive Control (MPC) can optimise biomanufacturing operations and ensure consistent product yields. With biological systems becoming increasing complex, alongside expanding demand for precision in drug development and manufacturing, advanced process control methods that can ensure consistent product yields and high-quality outputs in bioproduction are becoming vital, the researchers acknowledg
PharmaVoice
JANUARY 12, 2024
From regulatory concerns to leadership skills, pharma leaders at JPM shared how they’re approaching the coming year.
European Pharmaceutical Review
JANUARY 12, 2024
A recent survey from the Pistoia Alliance revealed that AI and machine learning (ML) will be the top technology investment for 60 percent of life sciences companies over the next two years. 1 AI and machine learning (ML) will be the top technology investment for 60 percent of life sciences companies over the next two years” With this increased focus on AI/ML, EPR editor Caroline Peachey sat down with Henry Levy, President of Life Sciences at Clarivate, to discuss the status, challenges a
Pharmacy Times
JANUARY 12, 2024
BrainSee creates a new standard for progression prediction in Alzheimer disease, marking a step forward in brain health management with non-invasive screening.
Pharmaceutical Technology
JANUARY 12, 2024
The US Department of Defense procurement contract for Emergent’s BioThrax is comprised of an initial five-year base agreement.
Pharmacy Times
JANUARY 12, 2024
RSV could interact with nerve cells, causing nerve damage and possible entry to the spinal cord.
Pharmatutor
JANUARY 12, 2024
Overview of FDA Drug approvals in 2023 - Total Guide admin Sat, 01/13/2024 - 11:38 In 2023, FDA approved 55 new drugs never before approved or marketed in the U.S., known as “novel” drugs. We also made other important approval decisions, such as expanding the use or patient population of previously approved drugs.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmacy Times
JANUARY 12, 2024
We owe it to our seniors to listen to their needs and ensure pharmacists have the support they need to continue to play a vital role in our communities as frontline providers of essential health care.
Contrarian Sales Techniques
JANUARY 12, 2024
"Mr. Johnson gripped the steering wheel like a white-knuckled life raft, eyes wide as saucers as we navigated the dealership's obstacle course. 'Is this normal?' he croaked, as the shiny red SUV bounced over a speed bump like a startled gazelle. 'Because it feels like I'm about to launch us into orbit.' I chuckled, calming his nerves with a reassuring, 'Just testing the suspension, Mr.
Pharmacy Times
JANUARY 12, 2024
With the increase in counterfeit GLP-1 and GLP/GIP medications available online, education may be needed for patients around the dangers of unregulated medications.
Pharmaceutical Commerce
JANUARY 12, 2024
RemeGen Co. Ltd’s antibody-drug conjugate RC88 is being analyzed to treat platinum-resistant recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Pharmacy Times
JANUARY 12, 2024
The results also indicated that stress and blood sugar levels were higher among women who had a college degree and women with a higher income.
Pharmaceutical Commerce
JANUARY 12, 2024
Morgan Company report makes the case for expanding coverage for GLP-1s beyond diabetes treatment and into the weight loss class, but are employers on board?
PharmExec
JANUARY 12, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Penrod
JANUARY 12, 2024
Tracking Technologies and HIPAA OCR Guidelines In December 2022, OCR issued a Bulletin outlining health providers’ HIPAA obligations. An important aspect of this overview emphasizes that providers are not allowed to use tracking technologies in a way that would reveal Protected Health Information (PHI) in a manner inconsistent with HIPAA’s privacy standards.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
293 
Let's personalize your content